Details for Patent: 11,648,256

« Back to Dashboard

Which drugs does patent 11,648,256 protect, and when does it expire?

Patent 11,648,256 protects DUOBRII and is included in one NDA.

This patent has thirty-two patent family members in nineteen countries.

Summary for Patent: 11,648,256

Title:	Topical compositions and methods for treating psoriasis
Abstract:	Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.
Inventor(s):	Gordon J. Dow, Radhakrishnan Pillai, Varsha D. Bhatt
Assignee:	Bausch Health Ireland Ltd
Application Number:	US17/993,817
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 11,648,256
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 11,648,256

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bausch	DUOBRII	halobetasol propionate; tazarotene	LOTION;TOPICAL	209354-001	Apr 25, 2019	AB	RX	Yes	Yes	11,648,256		Y			TOPICAL TREATMENT OF PLAQUE PSORIASIS IN ADULTS

International Family Members for US Patent 11,648,256

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016279801
Brazil	112017027332
Brazil	112019023817
Canada	2988577
Canada	3063371